Importance: There have been recent calls for increased access to mental health services, but access may be limited owing to psychiatrist refusal to accept insurance.
Objective: To describe recent trends in acceptance of insurance by psychiatrists compared with physicians in other specialties.
Design, Setting, And Participants: We used data from a national survey of office-based physicians in the United States to calculate rates of acceptance of private noncapitated insurance, Medicare, and Medicaid by psychiatrists vs physicians in other specialties and to compare characteristics of psychiatrists who accepted insurance and those who did not.
Main Outcomes And Measures: Our main outcome variables were physician acceptance of new patients with private noncapitated insurance, Medicare, or Medicaid. Our main independent variables were physician specialty and year groupings (2005-2006, 2007-2008, and 2009-2010).
Results: The percentage of psychiatrists who accepted private noncapitated insurance in 2009-2010 was significantly lower than the percentage of physicians in other specialties (55.3% [95% CI, 46.7%-63.8%] vs 88.7% [86.4%-90.7%]; P < .001) and had declined by 17.0% since 2005-2006. Similarly, the percentage of psychiatrists who accepted Medicare in 2009-2010 was significantly lower than that for other physicians (54.8% [95% CI, 46.6%-62.7%] vs 86.1% [84.4%-87.7%]; P < .001) and had declined by 19.5% since 2005-2006. Psychiatrists' Medicaid acceptance rates in 2009-2010 were also lower than those for other physicians (43.1% [95% CI, 34.9%-51.7%] vs 73.0% [70.3%-75.5%]; P < .001) but had not declined significantly from 2005-2006. Psychiatrists in the Midwest were more likely to accept private noncapitated insurance (85.1%) than those in the Northeast (48.5%), South (43.0%), or West (57.8%) (P = .02).
Conclusions And Relevance: Acceptance rates for all types of insurance were significantly lower for psychiatrists than for physicians in other specialties. These low rates of acceptance may pose a barrier to access to mental health services.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967759 | PMC |
| http://dx.doi.org/10.1001/jamapsychiatry.2013.2862 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acceptance of Insurance by Psychiatrists and Other Physicians, 2007-2016.
Psychiatr Serv
January 2024
Meadows Mental Health Policy Institute, Dallas (Carlo); Department of Psychiatry and Behavioral Sciences (Carlo, Jordan) and Center for Health Services and Outcomes Research, Institute for Public Health and Medicine (Jordan), Northwestern University Feinberg School of Medicine, Chicago; Departments of Pharmacy, Health Services, and Economics (Basu) and Department of Psychiatry and Behavioral Sciences (Unützer), University of Washington, Seattle.
Objective: The authors aimed to analyze psychiatrists' and other physicians' acceptance of insurance and the associations between insurance acceptance and specific physician- and practice-level characteristics.
Methods: Using the restricted version of the National Ambulatory Medical Care Survey, January 2007-December 2016, the authors analyzed acceptance of private insurance, public insurance, and any insurance among psychiatrists compared with nonpsychiatrist physicians. Because data were considered restricted, all analyses were conducted at federal Research Data Center facilities.
Venlafaxine prescription claims among insured women of reproductive age and pregnant women, 2011-2016.
Birth Defects Res
August 2021
Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background: Some studies have reported associations between prenatal use of venlafaxine, a serotonin-norepinephrine reuptake inhibitor used for depressive and anxiety disorders, and some birth defects. We described the prevalence of venlafaxine prescription claims among privately insured women of reproductive age and pregnant women.
Methods: Venlafaxine prescription claims were examined using the IBM MarketScan Commercial Databases.
Medical expenditures for hypertensive disorders during pregnancy that resulted in a live birth among privately insured women.
Pregnancy Hypertens
March 2021
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States.
Objective: To estimate the excess maternal health services utilization and direct maternal medical expenditures associated with hypertensive disorders during pregnancy and one year postpartum among women with private insurance in the United States.
Study Design: We used 2008-2014 IBM MarketScan® Commercial Databases to identify women aged 15-44 who had a pregnancy resulting in live birth during 1/1/09-12/31/13 and were continuously enrolled with non-capitated or partially capitated coverage from 12 months before pregnancy through 12 months after delivery. Hypertensive disorders identified by diagnosis codes were categorized into three mutually exclusive types: preeclampsia and eclampsia, chronic hypertension, and gestational hypertension.
Treatment Discontinuation within 3 Years of Levothyroxine Initiation among Children Diagnosed with Congenital Hypothyroidism.
J Pediatr
August 2020
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA.
Objectives: To measure the rates of thyroid gland imaging and levothyroxine (L-T) discontinuation and to assess whether discontinuation was monitored with thyroid-stimulating hormone testing in subjects with congenital hypothyroidism.
Study Design: This is a retrospective analysis of claims data from the IBM MarketScan Databases for children born between 2010 and 2016 and continuously enrolled in a noncapitated employer-sponsored private health insurance plan or in Medicaid for ≥36 months from the date of the first filled L-T prescription.
Results: There were 263 privately insured and 241 Medicaid-enrolled children who met the inclusion criteria.
Prevalence and Factors Associated with Family Physicians Providing E-Visits.
J Am Board Fam Med
September 2020
From the American Board of Family Medicine, Lexington, KY (MRP, MD, LEP); Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL (KT, ARM); Department of Family and Community Medicine, University of Kentucky, Lexington, KY (LEP); Department of Family Medicine and Community Health, University of Florida, Gainesville, FL (AGM).
Purpose: The use of telemedicine has grown in recent years. As a subset of telemedicine, e-visits typically involve the evaluation and management of a patient by a physician or other clinician through a Web-based or electronic communication system. The national prevalence of e-visits by primary care physicians is unclear as is what factors influence adoption.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!